APA

Orlando G., Tariciotti L., Manzia T. M., Gravante G., Sorge R., Manuelli M., Pisani F., Di Cocco P., Scelzo C., Burke G. M., Soker S., Baiocchi L., Lerut J., Angelico M. & Tisone G. (20100902). Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. : Transplant infectious disease : an official journal of the Transplantation Society.

Chicago

Orlando G, Tariciotti L, Manzia T M, Gravante G, Sorge R, Manuelli M, Pisani F, Di Cocco P, Scelzo C, Burke G M, Soker S, Baiocchi L, Lerut J, Angelico M and Tisone G. 20100902. Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. : Transplant infectious disease : an official journal of the Transplantation Society.

Harvard

Orlando G., Tariciotti L., Manzia T. M., Gravante G., Sorge R., Manuelli M., Pisani F., Di Cocco P., Scelzo C., Burke G. M., Soker S., Baiocchi L., Lerut J., Angelico M. and Tisone G. (20100902). Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. : Transplant infectious disease : an official journal of the Transplantation Society.

MLA

Orlando G, Tariciotti L, Manzia T M, Gravante G, Sorge R, Manuelli M, Pisani F, Di Cocco P, Scelzo C, Burke G M, Soker S, Baiocchi L, Lerut J, Angelico M and Tisone G. Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. : Transplant infectious disease : an official journal of the Transplantation Society. 20100902.